Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.72
Delayed Data
As of Jun 25
 -0.06 / -2.16%
Today’s Change
1.29
Today|||52-Week Range
3.98
+71.07%
Year-to-Date

Today’s Trading

Previous close2.78
Today’s open2.83
Day’s range2.72 - 2.83
Volume525,845
Average volume (3 months)1,381,408
Market cap$389.1M
Data as of 4:00pm ET, 06/25/2019

Growth & Valuation

Earnings growth (last year)+18.11%
Earnings growth (this year)-20.26%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.45-7.10%
PRTAProthena Corporation...+0.29+3.03%
BDSIBioDelivery Sciences...-0.01-0.23%
BFRABiofrontera AG-0.47-2.76%
Data as of 4:00pm ET, 06/25/2019

Financials

Next reporting dateAugust 7, 2019
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$70.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph Truitt
Chief Operating Officer &
Executive Vice President
Paul Firuta
Corporate headquarters
Blue Bell, Pennsylvania

Forecasts